Record #66487
MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC
Publisher
Original paper date
Dec 12, 2018
Original DOI
Country
Institution
Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China · Anhui Medical University, Hefei, Anhui, 230032, P.R. China · Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, Guangdong 518036, P.R. China
Open access
No
Article type
Broad categories
Notes from Retraction Watch
See also: https://pubpeer.com/publications/AF5AF570AC1CAA676A86639ECAB256
Citation lifecycle
How this paper is being cited
Pre-retraction
0
Same day
0
Post-retraction
41
% post-retraction
100.0%
~0.0 citations/yr before retraction · ~5.5 citations/yr after
— citing papers
Who is still citing this work
Loading…